MedTrace Logo

Tibial Tubercle Distalisation and Accelerated Rehabilitation

NCT05854056 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2023-05-11

No results posted yet for this study

Summary

The goal of this clinical trial is to compare in distalising tibial tubercle osteotomy procedure group fast rehabilitation to traditional rehabilitation.

The main questions it aims to answer are:

* Will the novel accelerated rehabilitation protocol lead to faster recovery and improved functional outcome at 6, 12 and 24 weeks compared with the conservative rehabilitation protocol?
* Will the complication rate be similar in both groups?

Participants will be following fast rehabilitation or the traditional rehabilitation guidelines after distalising tibial tubercle osteotomy procedure according to the randomisation.

Researchers will compare fast rehabilitation group to the traditional rehabilitation group to see if recovery and functional outcome is improved in fast rehabilitation group and complication rate will be similar in both groups.

Conditions

  • Patella Alta
  • Tibial Tubercle Distalisation Osteotomy
  • Rehabilitation

Interventions

PROCEDURE

Accelerated rehabilitation protocol

See Arms section

PROCEDURE

Conservative rehabilitation protocol

See Arms section

Sponsors & Collaborators

  • Pihlajalinna Hospital, Tampere

    collaborator UNKNOWN

  • Tampere University Hospital

    lead OTHER

Principal Investigators

  • Frederick Weitz · Pihlajalinna

  • Ville M Mattila, Prof · Department of Orthopaedic Surgery, Tampere University Hospital, Tampere, Finland

  • Erkki Nilkku · Pihlajalinna

  • Petri J Sillanpää · Pihlajalinna

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-30
Primary Completion
2024-09-30
Completion
2025-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05854056 on ClinicalTrials.gov